Annual General Meeting
The General Meeting is the company’s highest decision-making body. At the General Meeting, Careium AB’s board of directors and the chair of the board are elected. The company’s auditors are also appointed.
Careium’s Annual General Meeting 2026
Notice
The shareholders of Careium AB (publ), Reg. No. 559121-5875 (“Careium” or the “company”), are hereby summoned to the Annual General Meeting on Thursday, 23 April 2026, 13:00 CEST, at Sankt Gertrud Konferens, Östergatan 7B, 211 25 Malmö. Registration commences at 12:00 CEST. Prior to the Annual General Meeting, light refreshments and beverages will be served.
Right to attend and notification
In order to attend the Annual General Meeting, shareholders shall be registered in the share register kept by Euroclear Sweden AB as of Wednesday 15 April 2026.
Further, shareholders who wish to participate in the Annual General Meeting shall give notice of participation to the company no later than Friday 17 April 2026. Notice of participation shall be made:
- by mail to TM & Partners Law KB, Attn: Johanna Sternudd, marked “Careium AB’s Annual
- General Meeting 2026”, Jakobs torg 3, SE-111 52 Stockholm, Sweden, or
- by e-mail to johanna.sternudd@tmpartners.se
The notice of participation should state name, personal identification number or corporate registration number, postal address, telephone number, shareholding and, where applicable, information about any proxy or shareholder assistants at the Annual General Meeting. Shareholders or their proxies may bring a maximum of two assistants, provided that their attendance is notified as above.
Nominee-registered shares
In order to be entitled to attend the Annual General Meeting, a shareholder whose shares are nominee-registered shall, in addition to giving notice of participation in the Annual General Meeting, register its shares in its own name so that the shareholder is registered in the share register kept by Euroclear Sweden AB as of the record date on Wednesday 15 April 2026. Such registration may be temporary (so-called voting rights registration), and request for such voting rights registration shall be made to the nominee in accordance with the nominee’s routines at such a time in advance as decided by the nominee. Voting rights registrations made no later than the second banking day after Wednesday 15 April 2026 are taken into account in the presentation of the share register
Proxy etc.
If a shareholder is represented by proxy, a written and dated power of attorney signed by the shareholder must be issued for the proxy. The power of attorney must not have been issued earlier than one year before the date of the Annual General Meeting, unless the power of attorney provides for a longer period, however, not exceeding five years from issuance. The original power of attorney as well as registration certificate and other authorization documents, evidencing the authorized representative,should well in advance of the Annual General Meeting be sent by mail to TM & Partners Law KB, Attn: Johanna Sternudd, marked “Careium AB’s Annual General Meeting 2026”, Jakobs torg 3, SE-111 52 Stockholm, Sweden, or by e-mail to johanna.sternudd@tmpartners.se. Proxy form is available on the company’s website, www.careium.com, and is upon request sent to the shareholders who provide their postal address.
Shareholders’ right to receive information
Shareholders’ right to receive information The Board of Directors and the Chief Executive Officer shall, if any shareholder so requests and the Board of Directors believes that it can be done without material harm to the company, provide information at the Annual General Meeting about circumstances that may affect the evaluation of an item on the agenda, circumstances that may affect the evaluation of the company’s or subsidiaries’ financial position and the company’s relation to other group companies.
Documents General Meeting 2026
| Notice of Annual General Meeting 2026 | View Report |
| Proxy form Annual General Meeting 2026 | View Report |
| The Board’s proposal on issue authorization | View Report |
| The Board’s proposal for guidelines for remuneration to senior executives | View Report |
| The Board’s proposal for resolution on addendum to Employee Stock Option Program | View Report |
| The Nomination Committee’s complete proposals | View Report |
| Grant notice and agreement including terms for Board SHP 2026 | View Report |
| Terms and conditions for warrants of series 2026-2030 | View Report |